CLINISELECT PG Trademark Information

Trademark by Nethra Sambamoorthi

Clinical Trials and for drug target discovery for Pharmaceuticals

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: CLINISELECT PG
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
8/15/2005
Serial Number: 78422317
Filing Date: 5/20/2004
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Clinical Trials and for drug target discovery for Pharmaceuticals
Mark Description: The mark consists of CliniSelect PG is a novel hardware and software tool equipped with a web-browseable methodology to enable Phase III pharmaceutical clinical trial services (PCTS) following post-genomics (PG) specifications and requirements, where the right patients for the right disease state are included. The hardware and software components bring together specific disease profiles, patient demographics, genotype profiles of matched healthy and afflicted subjects, and related queriable kno
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Nethra Sambamoorthi
********
********
***** ****
Mark Drawing Code: Drawing with Words in Stylized form
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
8/15/2005
Correspondent Search:
Nethra Sambamoorthi is a correspondent of CLINISELECT PG trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on